Patent classifications
A61M2205/05
COMPONENTS FOR USE IN COMBINATION EXTERNAL FIXATION AND NEGATIVE PRESSURE WOUND THERAPY SYSTEM AND METHODS OF PRODUCTION AND USE THEREOF
Devices for use with combined external fixation and negative pressure wound therapy systems are disclosed. These devices include a clamping grommet for disposal about a percutaneous device and a wound dressing. Systems and kits including these devices, as well as methods of production and use thereof, are also disclosed.
IMPLANTABLE CARDIAC VALVE IMPROVEMENT DEVICE AND PROCEDURE FOR TREATING INSUFFICIENT CLOSING OF A CARDIAC VALVE
An implantable medical device for transcatheter delivery, which includes an anchor unit (100) configured to be anchored at an annulus of a cardiac valve of a patient, at least one coupling unit (200) that extends along a first length radially from said anchor unit (100) towards a coaptation line of said valve and including an extension unit (400) extending along a second length. The extension unit (400) is configured to cross between the leaflets of the cardiac valve in order to fill out for an insufficient closing of the valve leaflets of said cardiac valve.
Progression-based kit system for mimicking plastic surgery results
A kit system has a beginning level kit apparatus, an intermediate level kit apparatus, and an advanced kit apparatus. The beginning level kit apparatus has a first derma roller having a head with a plurality of needles each having a length of five tenths millimeters situated thereon. Additionally, the beginning level kit apparatus has a first chemical compound comprising vitamin A.sub.1 at a first potency. The beginning level kit apparatus also has a first red light therapy device that that is configured to emit red light having a wavelength in the range of six hundred ten nanometers to seven hundred nanometers for a predetermined minimum time period of ten minutes. Finally, the beginning level kit apparatus has a beginning level enclosure apparatus that that encloses the first derma roller, the first chemical compound, and the first red light therapy device.
CARDIOPULMONARY RESUSCITATION SYSTEM
A cardiopulmonary resuscitation system capable of avoiding fighting in an asynchronous mode in which sternum compression and artificial respiration are performed independently and continuously. The cardiopulmonary resuscitation system includes: a sternum compressor that includes an impact hammer for compressing the chest of a patient and repeats a sternum compression cycle having, as one cycle, a compression period in which the impact hammer is pressed against the chest and a recoil period in which the impact hammer is separated from the chest; an artificial respirator that repeats an artificial respiration cycle having, as one cycle, an inhalation period in which respiratory gas is supplied to the patient and an exhalation period in which supply of the respiratory gas is stopped; and a controller that controls the artificial respirator and the sternum compressor, the controller executes the artificial respiration cycle a predetermined number of times per unit time while executing the sternum compression cycle a predetermined number of times per unit time, and stops pressing the impact hammer against the chest during the compression period overlapping with the inhalation period.
PROCESS FOR SUPPORTING BLOOD GAS EXCHANGE BY VENTILATION AND EXTRACORPOREAL BLOOD GAS EXCHANGE AND SYSTEM OPERATING ACCORDING TO THE PROCESS
A system (10) for supporting the blood gas exchange of a patient (12) by means of a ventilator (14) as well as by means of a CO.sub.2 removal device (16), and a process for operating such a system (10), wherein a measured value concerning an expiratory or end-expiratory CO.sub.2 concentration in the breathing gas of the patient (12) can be detected by means of a sensor system (20), wherein a measured value can be selected as a start value by means of an operating action, wherein a trend parameter can be determined with the start value and with a respective, currently determined measured value and wherein a difference of a set point for the trend parameter and a respective, current value of the trend parameter can be fed to a controller (42), which acts on the CO.sub.2 removal device.
METHOD AND SYSTEM FOR PROVIDING ACTIVE TISSUE SITE DEBRIDEMENT
A wound debridement system includes a wound dressing having an active layer (40) and a wound interface layer (10). The active layer is formed from one or more pneumatic members (45). The pneumatic members are arranged about a film layer (60), by which the pneumatic members are attached to the wound interface layer. A control unit (80) controls a drive unit (70) to intermittently apply pressure to the pneumatic members of the active layer. The pressure applied by the drive unit causes the pneumatic members to expand and contract. This movement of the pneumatic members is transferred to the wound interface layer, causing the wound interface layer to move relative to a tissue site to which the wound dressing is applied. The wound interface layer may be formed having an abrasive wound-facing surface, such that the movement of the wound interface layer causes a mechanical disruption and debridement of debris at the tissue site.
METHOD, SYSTEM AND DEVICE FOR ASSISTED SLEEP
The methods, systems and devices provided herein relate to sleep-aid. Some embodiments include a vibration source and/or a sound source. In some embodiments, the vibration source and/or sound source emit vibrations and/or sounds that stimulate a subject's vagus nerve, or another nerve, to induce sleep or relaxation in the subject.
Utilizing Pressure Measurements to Detect Reuse of Patient Lines
A fluid injector system configured to perform an injection protocol in connection with a diagnostic imaging procedure includes a memory for storing a predetermined pressure profile representative of pressure expected to be generated within an exemplary administration line by a priming fluid, and a control device operatively associated with a drive component to pressurize and inject at least one fluid through a subject administration line. The control device includes a processor configured to perform an operation including: actuating the drive component to prime the subject administration line; determining a distinct pressure profile indicative of a measurement of current pressure generated during the priming of the subject administration line; comparing the distinct pressure profile to the predetermined pressure profile; and determining, based on a result of the comparison, whether the subject administration line, prior to priming, contained at least one of a liquid or a gas as the extant fluid.
RESPIRATORY THERAPEUTIC ELECTRIC HEAT SOURCE FACE MASK
A therapeutic face mask apparatus for wearers with resistant respiratory viruses, is connected to a heat gun that provides adjustable heated and humidified air for inhalation. The heat gun heats ambient air that is breathed in through the face mask during normal breathing, which is worn over the nose and mouth of a person. A temperature gauge monitors temperature for future adjustment of the amount of heat generating current to raise the heat to a predetermined temperature to deactivate resistant viruses in compromised upper and/or lower respiratory systems of the wearer. The air in the chamber is heated for inhalation by a resistive element in the heat gun. The temperature of the resistive material (and by extension the warm air generated), is regulated/adjusted by increasing or decreasing the current output settings on the power source, so that heated and pressured air is produced.
MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS
Devices, systems, and methods for delivering fluid therapy to a patient are disclosed herein. An exemplary method can comprise obtaining a urine output rate from a patient; causing a diuretic to be provided to the patient at a dosage rate, wherein the dosage rate is increased over a period of time such that the urine output rate increases to be above a predetermined threshold within the period of time; and causing a hydration fluid to be provided to the patient at a hydration rate. The hydration rate can be set based on the urine output rate to drive net fluid loss from the patient.